Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.

about

Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.When do coinfections matter?

P2860

Q38680503-340BB27A-278B-473B-9CB2-B0C6D1272995 Q53835536-7FE14C4E-AA16-413E-B7D4-5732EB7AFC9E

P2860

Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.

Item

http://www.wikidata.org/entity/Q38805328

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Benefits of continuous isoniaz ...... g tuberculosis/HIV coepidemic.

@en

type

Item

label

Benefits of continuous isoniaz ...... g tuberculosis/HIV coepidemic.

@en

prefLabel

Benefits of continuous isoniaz ...... g tuberculosis/HIV coepidemic.

@en

P1476

Benefits of continuous isoniaz ...... g tuberculosis/HIV coepidemic.

@en

P2093

Amber Kunkel

http://www.w3.org/2001/XMLSchema#string

Forrest W Crawford

http://www.w3.org/2001/XMLSchema#string

James Shepherd

http://www.w3.org/2001/XMLSchema#string

Ted Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of latent tuberculosis infection in HIV infected persons

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.

Assessing tuberculosis case fatality ratio: a meta-analysis.

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.

Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.

P304

2715-2723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001235

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27782966

http://www.w3.org/2001/XMLSchema#string

P932

5089846

http://www.w3.org/2001/XMLSchema#string

Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.

about

P2860

P2860

Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932